File Download
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1158/1538-7445.AM2013-4309
- Find via

Supplementary
-
Citations:
- Appears in Collections:
Conference Paper: Fibulin-2 suppresses tumor growth and angiogenesis through the inhibition of Erk1/2 and p65 pathways in nasopharyngeal carcinoma
| Title | Fibulin-2 suppresses tumor growth and angiogenesis through the inhibition of Erk1/2 and p65 pathways in nasopharyngeal carcinoma |
|---|---|
| Authors | |
| Keywords | Medical sciences Oncology |
| Issue Date | 2013 |
| Publisher | American Association for Cancer Research. The Journal's web site is located at http://cancerres.aacrjournals.org/ |
| Citation | The 104th Annual Meeting of the American Association of Cancer Research (AACR), Washington, DC., 6-10 April 2013. In Cancer Research, 2013, v. 73 n. 8 suppl., abstract 4309 How to Cite? |
| Abstract | Nasopharyngeal carcinoma (NPC) has distinctive ethnic and geographic distributions, with the highest incidence in Southern China. Infection with the human herpesvirus, Epstein-Barr virus, genetic predisposition, dietary, and environmental factors are high-risk factors for the development of NPC. Evidence indicates that loss of heterozygosity on chromosome 3 is one of the early events contributing to the cancerization of normal nasopharyngeal epithelial cells. By using a chromosome 3 NotI genomic microarray, Fibulin-2 (FBLN2) mapping to chromosome 3p25.1, was previously identified as a ... |
| Description | Poster Session 34 - Signaling Pathways in Cancer Cells: abstract 4309 This journal suppl. entitled: Proceedings: AACR 104th Annual Meeting 2013 ... |
| Persistent Identifier | http://hdl.handle.net/10722/186921 |
| ISSN | 2023 Impact Factor: 12.5 2023 SCImago Journal Rankings: 3.468 |
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Shuen, WH | en_US |
| dc.contributor.author | Lung, ML | en_US |
| dc.date.accessioned | 2013-08-20T12:25:01Z | - |
| dc.date.available | 2013-08-20T12:25:01Z | - |
| dc.date.issued | 2013 | en_US |
| dc.identifier.citation | The 104th Annual Meeting of the American Association of Cancer Research (AACR), Washington, DC., 6-10 April 2013. In Cancer Research, 2013, v. 73 n. 8 suppl., abstract 4309 | en_US |
| dc.identifier.issn | 0008-5472 | - |
| dc.identifier.uri | http://hdl.handle.net/10722/186921 | - |
| dc.description | Poster Session 34 - Signaling Pathways in Cancer Cells: abstract 4309 | - |
| dc.description | This journal suppl. entitled: Proceedings: AACR 104th Annual Meeting 2013 ... | - |
| dc.description.abstract | Nasopharyngeal carcinoma (NPC) has distinctive ethnic and geographic distributions, with the highest incidence in Southern China. Infection with the human herpesvirus, Epstein-Barr virus, genetic predisposition, dietary, and environmental factors are high-risk factors for the development of NPC. Evidence indicates that loss of heterozygosity on chromosome 3 is one of the early events contributing to the cancerization of normal nasopharyngeal epithelial cells. By using a chromosome 3 NotI genomic microarray, Fibulin-2 (FBLN2) mapping to chromosome 3p25.1, was previously identified as a ... | - |
| dc.language | eng | en_US |
| dc.publisher | American Association for Cancer Research. The Journal's web site is located at http://cancerres.aacrjournals.org/ | - |
| dc.relation.ispartof | Cancer Research | en_US |
| dc.subject | Medical sciences | - |
| dc.subject | Oncology | - |
| dc.title | Fibulin-2 suppresses tumor growth and angiogenesis through the inhibition of Erk1/2 and p65 pathways in nasopharyngeal carcinoma | en_US |
| dc.type | Conference_Paper | en_US |
| dc.identifier.email | Lung, ML: mlilung@hku.hk | en_US |
| dc.identifier.authority | Lung, ML=rp00300 | en_US |
| dc.description.nature | link_to_OA_fulltext | - |
| dc.identifier.doi | 10.1158/1538-7445.AM2013-4309 | - |
| dc.identifier.hkuros | 218580 | en_US |
| dc.identifier.volume | 73 | - |
| dc.identifier.issue | 8 suppl., abstract 4309 | - |
| dc.publisher.place | United States | - |
| dc.identifier.issnl | 0008-5472 | - |
